Hudson Bay Capital Management’s Moderna MRNA Stock Holding History

Hudson Bay Capital Management’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.64M	Buy	+23,401	New	+$1.21M	﹤0.01%	849
2026 Q1	–	Sell	-244,594	Closed	-$7.21M	–	1521
2025 Q4	$7.21M	Buy	244,594 +189,594	+345%	+$5.15M	0.02%	404
2025 Q3	$1.42M	Sell	55,000 -20,000	-27%	-$558K	﹤0.01%	807
2025 Q2	$2.07M	Buy	75,000 +39,020	+108%	+$1.03M	0.01%	786
2025 Q1	$1.02M	Sell	35,980 -464,039	-93%	-$16.5M	﹤0.01%	920
2024 Q4	$20.8M	Buy	+500,019	New	+$23.9M	0.07%	239
2024 Q1	–	Sell	-5,000	Closed	-$497K	–	834
2023 Q4	$497K	Sell	5,000 -10,000	-67%	-$841K	﹤0.01%	556
2023 Q3	$1.55M	Buy	15,000 +2,500	+20%	+$279K	0.01%	515
2023 Q2	$1.52M	Buy	+12,500	New	+$1.67M	0.01%	536
2022 Q1	–	Sell	-10,000	Closed	-$1.68M	–	1266
2021 Q4	$2.54M	Buy	+10,000	New	+$2.92M	0.03%	601
2021 Q1	–	Sell	-42,200	Closed	-$4.41M	–	915
2020 Q4	$4.41M	Buy	+42,200	New	+$4.27M	0.05%	255

Other funds holding MRNA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Hudson Bay Capital Management's MRNA Position: Q2 2026 in Review

Hudson Bay Capital Management opened a new position in Moderna (MRNA) in Q2 2026: 23,401 shares worth $1.64M. The stake represents ﹤0.01% of the portfolio and ranks #849 among its holdings. This is a return to the name: Hudson Bay Capital Management previously reported a position in MRNA as recently as Q4 2025.

Hudson Bay Capital Management first reported a position in MRNA in Q4 2020 and has held it in 11 quarters since. The position peaked at $20.8M in Q4 2024. 780 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

Hudson Bay Capital Management held 23,401 shares of Moderna worth $1.64M as of Q2 2026.
Moderna was a new Hudson Bay Capital Management position in Q2 2026.
Moderna made up ﹤0.01% of Hudson Bay Capital Management's portfolio in Q2 2026, its #849 holding.
Hudson Bay Capital Management first reported a position in Moderna in Q4 2020 and has held it in 11 quarters since.
Hudson Bay Capital Management's Moderna position peaked at $20.8M in Q4 2024.
780 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Hudson Bay Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.